PT2385 : Activation of intestinal hypoxia-inducible factor 2α during obesity contributes to hepatic steatosis
BMS202 : Combination of Chidamide-Mediated Epigenetic Modulation with Immunotherapy: Boosting Tumor Immunogenicity and Response to PD-1/PD-L1 Blockade
Wortmannin : hTERT-molecular targeted therapy of ovarian cancer cells via folate-functionalized PLGA nanoparticles co-loaded with MNPs/siRNA/wortmannin
Ebselen:Protective efficacy of thymoquinone or ebselen separately against arsenic-induced hepatotoxicity in rat
2-Hydroxybenzylamine : Spectroscopic studies of metal complexes with redox-active hydrogenated Schiff bases
Trastuzumab Emtansine: Trastuzumab emtansine delays and overcomes resistance to the third- generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines
Tolinapant : Dose escalation of tolinapant (ASTX660) in combination with standard radical chemoradiotherapy in cervical cancer : a study protocol for a phase 1b TiTE-CRM clinical trial (CRAIN) in UK secondary care centres
TP0427736 : GRP78 secreted by tumor cells stimulates differentiation of bone marrow mesenchymal stem cells to cancer-associated fibroblasts
ε-poly-L-lysine: A facile injectable carbon dot/oxidative polysaccharide hydrogel with potent self-healing and high antibacterial activity